Marnix H. Geukes Foppen

Author

Also Known As

M H Geukes Foppen, M.H. Geukes Foppen, MariekeA Peters, Marnix H Geukes Foppen, Marnix H. Geukes Foppen, Marnix Heimen Geukes Foppen

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Oncode Institute University Hospital of Zurich Molecular Oncology (United States)University of Twente

About

Marnix H. Geukes Foppen is an author at The Netherlands Cancer Institute specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	4K
2	Immunology	4	4	3.1K
3	Health Sciences	2	2	193
4	Cell Biology	2	2	657
5	Neurology	1	1	36

Marnix H. Geukes Foppen

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma Eliezer M. Van Allen, Diana Miao, Bastian Schilling, Science Immune EvasionCancer ImmunosurveillanceImmune Checkpoint ActivityMedicineMelanoma	2015	2.9K
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma Judith M. Müller, Oscar Krijgsman, Jennifer Tsoi, Nature Communications Tumor BiologyOncologyMedicineMelanomaLow Mitf/axl Ratio	2014	621
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma Maartje W. Rohaan, Troels Holz Borch, Joost H. van den Berg, New England Journal of Medicine	2022	474
Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma Yanina Jansen, Elisa A. Rozeman, Robert M. Mason, Annals of Oncology	2019	222
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up Joost H. van den Berg, Bianca Heemskerk, Nienke van Rooij, Journal for ImmunoTherapy of Cancer	2020	184
Cancer drug addiction is relayed by an ERK2-dependent phenotype switch Xiangjun Kong, Thomas Kuilman, Aida Shahrabi, Nature OncologyAddictionMedicinePharmacologyCancer Drug Addiction	2017	157
Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma Marcel A. Deken, Jules Gadiot, Ekaterina S. Jordanova, OncoImmunology	2016	144
Targeted treatment and immunotherapy in leptomeningeal metastases from melanoma Marnix H. Geukes Foppen, Dieta Brandsma, Christian U. Blank, Annals of Oncology Leptomeningeal MetastasesMelanomaImmunologyImmunotherapyMedicine	2016	85
Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial P.G.M. de Gooyer, Y.L. Verschoor, L.D.W. van den Dungen, Nature Medicine Gastrointestinal OncologyMedicineImmunologyPathologyColorectal Cancer	2024	80
Vemurafenib for BRAF V600 mutated advanced melanoma: Results of treatment beyond progression Asbjørn M. Scholtens, Marnix H. Geukes Foppen, Christian U. Blank, European Journal of Cancer MedicineMelanomaPathologyBraf V600Dermatology	2015	36

Page 1